Collectively, companies still owe AIFA €370 million of the €2.8 billion that industry has to rep...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreSpain will ask pharmaceutical companies to submit their economic evaluation studies to reviewed late...
Read moreGermany's BPI and vfa advise that the implementation of the European Health Technology Assessment (E...
Read moreOur experts provide an overview of the five key trends that could shape the pricing and market acces...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreOur client had established a precision medicine working group, but had limited knowledge of the term...
Read moreOur client asked Remap Consulting to support them in the development of a peer-reviewed publication ...
Read moreOur client needed a rapid pricing and market access (P&MA) assessment across the US and EU5 in sever...
Read moreDevelopment of an EU pricing and market access e-Learning training resource to provide awareness of ...
Read more